NOT-AI-24-084: Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine", NOT-AI-22-013

Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine", NOT-AI-22-013

Notice Number:

NOT-AI-24-084

Key Dates

Release Date:

November 21, 2024

Related Announcements

December 13, 2021 - Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine. See NOSI NOT-AI-22-013.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-22-013, “Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine,” will be expired as of November 21, 2024.

Potential applicants interested in this announcement are encouraged to consider NOT-AI-24-081, “Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine”.

Inquiries

Please direct all inquiries to:

Jennifer L. Gordon, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Division of Microbiology and Infectious Diseases
Telephone: 301-761-6805
Email: [email protected]

Kentner Singleton, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Division of Allergy, Immunology, and Transplantation
Telephone: 240-669-5499
Email: [email protected]